Insider Transactions in Q4 2020 at Hookipa Pharma Inc. (HOOK)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2020
|
Igor Matushansky Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
27,979
-16.37%
|
$307,769
$11.73 P/Share
|
|
Dec 17
2020
|
Igor Matushansky Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,988
+22.17%
|
$0
$0.1 P/Share
|
|
Dec 16
2020
|
Igor Matushansky Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
380
-0.67%
|
$4,180
$11.7 P/Share
|
|
Dec 16
2020
|
Igor Matushansky Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
640
+1.11%
|
$0
$0.1 P/Share
|
|
Oct 21
2020
|
Jan Van De Winkel |
BUY
Grant, award, or other acquisition
|
Direct |
9,153
+50.0%
|
-
|
|
Oct 21
2020
|
Michael Aaron Kelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,754
+50.0%
|
-
|
|
Oct 21
2020
|
David Ross Kaufman |
BUY
Grant, award, or other acquisition
|
Direct |
4,577
+50.0%
|
-
|
|
Oct 21
2020
|
Christoph Lengauer Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,603
+50.0%
|
-
|
|
Oct 21
2020
|
Julie O'Neill |
BUY
Grant, award, or other acquisition
|
Direct |
4,969
+50.0%
|
-
|
|
Oct 21
2020
|
Sander Van Deventer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,485
+50.0%
|
-
|
|
Oct 21
2020
|
Graziano Seghezzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,708
+50.0%
|
-
|
|
Oct 02
2020
|
Capital Vi Fcpr Sofinnova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
300
-0.01%
|
$3,000
$10.0 P/Share
|